Most pancreatic cancer isn’t caught until it’s late stage — a new blood test could change that
Scientists from Oregon Health & Science University have developed a blood test called PAC-MANN that is said to be less invasive, cheaper and more robust than traditional screening methods for ...
The new blood-based assay PAC-MANN-1 (protease activity–based cancer marker using magnetic nanosensor-1) identified pancreatic ductal adenocarcinoma (PDAC) across all stages with high specificity and ...
A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the deadliest cancers. Researchers at Oregon Health & Science University have ...
A new blood test developed by researchers at Oregon Health & Science University (OHSU) shows promise for the early detection of pancreatic cancer, a disease notorious for its high mortality rates due ...
Blood drawn from pancreatic cancer patients within weeks of starting chemotherapy can separate those likely to survive longest from those facing the shortest prognosis. In the phase III MPACT trial, ...
Add Yahoo as a preferred source to see more of our stories on Google. Scientists are developing a test that uses a tiny blood sample to detect pancreatic cancer in its early stages. If caught early, ...
Health and Me on MSN
Meet Audrey Zheng: 17-YO who developed blood test for pancreatic cancer that correctly identified 87% of patients
US-based high school student Audrey Zheng achieved a new milestone in pancreatic cancer detection by developing a promising new blood test.
A 17-year-old student from Pennsylvania has developed an innovative bioengineering method to detect early-stage pancreatic cancer from blood samples, tackling one of the biggest challenges in cancer ...
A new blood test that uses artificial intelligence (AI) may offer a faster, more accurate way to determine whether pancreatic cancer treatment is working. Known as ARTEMIS-DELFI, the test detects DNA ...
The blood test achieved high accuracy, with 98% specificity and 73% sensitivity for detecting pancreatic cancer. When combined with CA 19-9 biomarker testing, the sensitivity increased to 85% while ...
A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the deadliest cancers. Researchers at Oregon Health & Science University have ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results